Azenta, Inc. AZTA
45.65 USD +1.79 (+4.08%)
At closeNov 13, 2026, 4:00 PM EST
45.65 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
43.15 Day range 45.68
16.02 52-week range 48.90
- YTD
- +37.25%
- 1 year
- +52.78%
News
newsfilecorp.com ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
globenewswire.com Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc.…
fool.com Why Azenta Stock Crushed it on Wednesday Wednesday was an ideal day to be invested in Azenta's (AZTA +20.80%) stock. Investors fell over themselves buying shares of the healthcare tech company, and when the scramble subsided, the stock had…
benzinga.com Jefferies Maintains Buy on Azenta, Raises Price Target to $52 Jefferies analyst Matthew Stanton maintains Azenta (NASDAQ:AZTA) with a Buy and raises the price target from $44 to $52.
marketbeat.com What Azenta (AZTA) Said on Its Q4 Earnings Call Azenta NASDAQ: AZTA forecast faster organic revenue growth and higher profitability for fiscal 2027 after fourth-quarter sales exceeded expectations, as the company works to improve its automated…
seekingalpha.com Azenta, Inc. (AZTA) Q4 2026 Earnings Call Transcript Azenta, Inc. ( AZTA ) Q4 2026 Earnings Call November 11, 2026 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations Martin Madaus -…
investorplace.com Insider Buying Signals: 3 Healthcare Stocks to Watch Insider buying and share buybacks have put Prothena, Rapport Therapeutics and Azenta on the radar. See the catalysts and risks behind each stock.
benzinga.com Azenta Q4 Adj. EPS $0.28 Beats $0.11 Estimate, Sales $167.088M Beat $160.133M Estimate Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.11 by 154.55 percent. This is a 33.33 percent increase over earnings of $0.21 per…
prnewswire.com Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. Q4'26 reported revenue growth of 5% year over year and 2% on an organic basis FY'26 reported revenue growth of 5% year over year and 2% on an organic basis FY'27 reported revenue expected to range…
newsfilecorp.com ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
globenewswire.com Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc.…
gurufocus.com Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTAPR NewswireNEW YORK, Nov. 8, 2026NEW YORK, Nov. 8,
prnewswire.com Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA NEW YORK, Nov. 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ:…
newsfilecorp.com ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
newsfilecorp.com ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
globenewswire.com Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc.…
defenseworld.net Head to Head Comparison: Champions Oncology (NASDAQ:CSBR) versus Azenta (NASDAQ:AZTA) Azenta (NASDAQ: AZTA - Get Free Report) and Champions Oncology (NASDAQ: CSBR - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two…
newsfilecorp.com ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
prnewswire.com Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ:…
seekingalpha.com Azenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor Azenta is undervalued, with 30% of its market cap in cash and a strong recurring revenue base overlooked due to capital equipment struggles. Recurring streams now exceed 50% of revenue, and the…
newsfilecorp.com ROSEN, LEADING INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
newsfilecorp.com ROSEN, HIGHLY REGARDED TRIAL ATTORNEYS, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of…
benzinga.com Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo, PacBio and others posted double-digit gains.
benzinga.com Applied Digital, Bitdeer Technologies, ON Semiconductor And Other Big Stocks Moving Higher On Friday U.S. stocks rose Friday; Applied Digital jumped 9.8% after adding 75 MW of AI capacity, while numerous tech stocks posted gains.
benzinga.com Crude Oil Down 3%; XPeng Shares Fall After Q2 Results US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jumped while information technology stocks fell. XPeng Inc shares fell 7% due to wider than expected…
benzinga.com Azenta Appoints Martin Madaus Interim President, CEO; Co. Reiterates Q4 Revenue Outlook Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO,- benzinga.com Evercore ISI Group Maintains Outperform on Azenta, Raises Price Target to $35 Evercore ISI Group analyst Vijay Kumar maintains Azenta (NASDAQ:AZTA) with a Outperform and raises the price target from $28 to $35.
benzinga.com Needham Maintains Buy on Azenta, Raises Price Target to $37 Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and raises the price target from $33 to $37.
benzinga.com Azenta Narrows FY2026 Sales Guidance from $603.000M-$621.000M to $613.000M-$618.000M vs $600.458M Est Azenta (NASDAQ:AZTA) narrows FY2026 sales outlook from $603.000 million-$621.000 million to $613.000 million-$618.000 million vs $600.458 million estimate.
benzinga.com Azenta Q3 Adj. EPS $0.16 Beats $0.11 Estimate, Sales $161.000M Beat $149.288M Estimate Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.11 by 45.45 percent. This is a 15.79 percent decrease over earnings of $0.19 per…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Earnings Scheduled For February 4, 2026 
benzinga.com Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For November 21, 2025
benzinga.com This Coinbase Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session 
benzinga.com Earnings Scheduled For August 5, 2025 - benzinga.com Azenta Joins Frenova And Nephronomics To Power MyReason Genomics Program Aiming To Transform Precision CKM Disease Care Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin…
benzinga.com Earnings Scheduled For May 7, 2025 
benzinga.com Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday? Wall Street rose on Wednesday, with all major equity indices advancing as investors assessed the latest batch of corporate earnings and drew optimism from positive labor market data.- benzinga.com Earnings Scheduled For February 5, 2025
- benzinga.com Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com Earnings Scheduled For February 7, 2024 Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
- benzinga.com Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
- benzinga.com Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.